1. Home
  2. XENE vs FRME Comparison

XENE vs FRME Comparison

Compare XENE & FRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • FRME
  • Stock Information
  • Founded
  • XENE 1996
  • FRME 1893
  • Country
  • XENE Canada
  • FRME United States
  • Employees
  • XENE N/A
  • FRME N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • FRME Major Banks
  • Sector
  • XENE Health Care
  • FRME Finance
  • Exchange
  • XENE Nasdaq
  • FRME Nasdaq
  • Market Cap
  • XENE 2.5B
  • FRME 2.1B
  • IPO Year
  • XENE 2014
  • FRME N/A
  • Fundamental
  • Price
  • XENE $36.13
  • FRME $37.89
  • Analyst Decision
  • XENE Strong Buy
  • FRME Buy
  • Analyst Count
  • XENE 9
  • FRME 5
  • Target Price
  • XENE $56.22
  • FRME $44.90
  • AVG Volume (30 Days)
  • XENE 862.0K
  • FRME 284.8K
  • Earning Date
  • XENE 05-12-2025
  • FRME 04-24-2025
  • Dividend Yield
  • XENE N/A
  • FRME 3.68%
  • EPS Growth
  • XENE N/A
  • FRME 2.61
  • EPS
  • XENE N/A
  • FRME 3.55
  • Revenue
  • XENE N/A
  • FRME $615,411,000.00
  • Revenue This Year
  • XENE N/A
  • FRME $17.18
  • Revenue Next Year
  • XENE $1,553.36
  • FRME $3.90
  • P/E Ratio
  • XENE N/A
  • FRME $10.72
  • Revenue Growth
  • XENE N/A
  • FRME N/A
  • 52 Week Low
  • XENE $26.74
  • FRME $30.55
  • 52 Week High
  • XENE $46.00
  • FRME $46.13
  • Technical
  • Relative Strength Index (RSI)
  • XENE 49.08
  • FRME 55.94
  • Support Level
  • XENE $37.46
  • FRME $36.45
  • Resistance Level
  • XENE $39.01
  • FRME $38.31
  • Average True Range (ATR)
  • XENE 1.68
  • FRME 1.04
  • MACD
  • XENE -0.14
  • FRME 0.43
  • Stochastic Oscillator
  • XENE 48.59
  • FRME 87.72

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About FRME First Merchants Corporation

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.

Share on Social Networks: